A meta-analysis of proximal occlusion device outcomes in carotid artery stenting

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 7, 2012, Pages 1072-1078

  Bersin, Robert M ^a   Stabile, Eugenio ^b   Ansel, Gary M ^c   Clair, Daniel G ^d   Cremonesi, Alberto ^e   Hopkins, L Nelson ^f   Nikas, Dimitrios ^g   Reimers, Bernhard ^h   Sievert, Horst ⁱ   Rubino, Paolo ^b  

^a SWEDISH MEDICAL CENTER   (United States)

^b Clinica Montevergine   (Italy)

^c RIVERSIDE METHODIST HOSPITAL   (United States)

^d CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^e MARIA CECILIA HOSPITAL   (Italy)

^f UNIVERSITY AT BUFFALO   (United States)

^g Ioannina Public Hospital   (Greece)

^h Ospedale Civile   (Italy)

ⁱ CardioVascular Center Sankt Katharinen   (Germany)

Author keywords

cerebrovascular accident; cerebrovascular disease; myocardial infarction

Indexed keywords

AGE; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CEREBROVASCULAR ACCIDENT; DEATH; DEVICE SAFETY; DIABETES MELLITUS; EMBOLIC PROTECTION DEVICE; GENDER; HEART INFARCTION; HUMAN; INTERNAL CAROTID ARTERY; META ANALYSIS; MULTICENTER STUDY (TOPIC); NEUROPROTECTION; PREDICTIVE VALUE; PROXIMAL OCCLUSION DEVICE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY; CAROTID ARTERY DISEASES; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DATABASES, FACTUAL; DIABETES MELLITUS; EMBOLIC PROTECTION DEVICES; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NONLINEAR DYNAMICS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84870948120     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24433     Document Type: Article

References (24)

1. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ,. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/ CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. J Am Coll Cardiol 2011; 57: 1002-1044.
2. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M, Hopkins LN, Atkinson R, Raabe R, Barnwell S, Green R,; for the CAPTURE Trial Collaborators. The CAPTURE registry: Predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting. Catheter Cardiovasc Interv 2007; 70: 1025-1033.
3. Zahn R, Ischinger T, Hochadel M, Zeymer U, Schmalz W, Treese N, Eugen K, Hauptmann KE, Seggewiß H, Janicke, I, Haase H, Mudra H, Senges J,; for the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Carotid artery stenting in octogenarians: Results from the ALKK carotid artery stent (CAS) registry. Eur Heart J 2007; 28: 370-375.
4. Stingele R, Berger J, Alfke K, et al. Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: A sub analysis of the SPACE study. Lancet Neurol 2008; 7: 216-222.
5. Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF,; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363: 11-23.
6. Carotid Stenting Trialists' Collaboration. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: A preplanned meta-analysis of individual patient data. Lancet 2010; 376: 1062-1073.
7. Stabile E, Salemme L, Sorrropago G, et al. Proximal endovascular occlusion for carotid artery stenting: Results from a prospective registry of 1,300 patients. J Am Coll Cardiol 2010; 55: 1661-1667.
8. Clair DG, Hopkins LN, Mehta M, Kasirajan K, Schermerhorn M, Schönholz C, Kwolek CJ, Eskandari MK, Powell RJ, Ansel GM,; EMPiRE Clinical Study Investigators. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE clinical study. Catheter Cardiovasc Interv 2011; 77: 420-429.
9. ® proximal cerebral protection device during carotid artery stenting: Results from the ARMOUR pivotal trial. Catheter Cardiovasc Interv 2010; 76: 1-8.
10. Nikas D, Reith W, Schmidt A, Duda S, Mathias K, Cremonesi A, Dill H, Formgren J, Pieniazek JP, Musialek P, Hornung M, Sievert H, Reimers B,. Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. Catheter Cardiovasc Interv 2012; DOI 10.1002/ccd.24402.
11. Reimers B, Sievert H, Schuler GC, Tübler T, Diederich K, Schmidt A, Rubino P, Mudra H, Dudek D, Coppi G, Schofer J, Cremonesi A, Haufe M, Resta M, Klauss V, Benassi A, Di Mario C, Favero L, Scheinert D, Salemme L, Biamino G,. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: Results from a prospective multicenter registry. J Endovasc Ther 2005; 12: 156-165.
12. Stabile E, Pallav G, Cremonesi A, Bosiers M, Reimers B, Setacci C, Cao P, Schmidt A, Sievert H, Peeters P, Nikas D, Werner M, de Donato G, Parlani G, Castriota F, Hornung M, Mauri L, Rubino P,. European registry of carotid artery stenting: Results from a Prospective Registry of Eight High Volume EUROPEAN Institutions. Catheter Cardiovasc Interv 2012; DOI 10.1002/ccd.24348.
13. Coppi G, Moratto R, Silingardi P, Rubino P, Sorropago G, Salemme L, Cremonesi A, Castriota F, Manetti R, Sacca S, Reimers B,. PRIAMUS: PRoximal flow blockage cerebral protectIon during cArotid stenting. Results from a MUlticenter Italian regiStry. J Cardiovasc Surg (Torino) 2005; 46: 219-227.
14. Stijnen T, Hamza TH, Ozdemir P,. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Statist Med 2010; 29: 3046-3067.
15. Rabe K, Sugita J, Gödel H, Sievert H,. Flow-reversal device for cerebral protection during carotid artery stenting-Acute and long-term results. J Interv Cardiol 2006; 19: 55-62.
16. Schmidt A, Diederich KW, Scheinert S, Bräunlich S, Olenburger T, Biamino G, Schuler G, Scheinert D,. Effect of two different neuroprotection systems on microembolization during carotid artery stenting. J Am Coll Cardiol 2004; 44: 1966-1969.
17. Garami ZF, Bismuth J, Charlton-Ouw KM, Davies MG, Peden EK, Lumsden AB,. Feasibility of simultaneous pre- and postfilter transcranial Doppler monitoring during carotid artery stenting. J Vasc Surg 2009; 49: 340-345.
18. Müller-Hülsbeck S, Jahnke T, et al. Comparison of various cerebral protection devices used for carotid artery stent placement: An in vitro experiment. J Vasc Interv Radiol 2003; 14: 613-620.
19. Siewiorek GM, Wholey MH, Finol EA,. In vitro performance assessment of distal protection filters: Pulsatile flow conditions. J Endovasc Ther 2009; 16: 735-743.
20. Ohki T, Parodi J, Veith FJ, Bates M, Bade M, Chang D, Mehta M, Rabin J, Goldstein K, Harvey J, Lipsitz E,. Efficacy of a proximal occlusion catheter with reversal of flow in the prevention of embolic events during carotid artery stenting: An experimental analysis. J Vasc Surg 2001; 33: 504-509.
21. Rapp JH, Zhu L, Hollenbeck K, et al. Distal filtration versus flow reversal: An ex vivo assessment of the choices for carotid embolic protection. J Vasc Surg 2009; 49: 1181-1188.
22. Montorsi P, Caputi L, Galli S, Ciceri E, Ballerini G, Agrifoglio M, Ravagnani P, Trabattoni D, Pontone G, Fabbiocchi F, Loaldi A, Parati E, Andreini D, Veglia F, Bartorelli AL,. Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection. J Am Coll Cardiol 2011; 58: 1656-1663.
23. Bijuklic K, Wandler A, Hazizi F, Schofer J,. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): A prospective randomized trial. J Am Coll Cardiol 2012; 59: 1383-1389.
24. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ CirculatorySystemDevicesPanel/UCM248647.pdf.